Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $463.75 million. The enterprise value is $301.48 million.
| Market Cap | 463.75M |
| Enterprise Value | 301.48M |
Important Dates
The last earnings date was Thursday, March 20, 2025, before market open.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 44.12 million shares outstanding.
| Current Share Class | 44.12M |
| Shares Outstanding | 44.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +54.85% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 7.63% |
| Float | 15.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.49, with a Debt / Equity ratio of 0.06.
| Current Ratio | 14.49 |
| Quick Ratio | 14.16 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.44% and return on invested capital (ROIC) is -39.90%.
| Return on Equity (ROE) | -61.44% |
| Return on Assets (ROA) | -37.10% |
| Return on Invested Capital (ROIC) | -39.90% |
| Return on Capital Employed (ROCE) | -40.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.50M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 22.60 |
| Average Volume (20 Days) | 235,801 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.56M |
| Pretax Income | -57.72M |
| Net Income | -61.69M |
| EBITDA | -69.89M |
| EBIT | -70.56M |
| Earnings Per Share (EPS) | -$15.99 |
Balance Sheet
The company has $147.54 million in cash and $9.75 million in debt, giving a net cash position of $158.29 million or $3.59 per share.
| Cash & Cash Equivalents | 147.54M |
| Total Debt | 9.75M |
| Net Cash | 158.29M |
| Net Cash Per Share | $3.59 |
| Equity (Book Value) | 166.66M |
| Book Value Per Share | -34.66 |
| Working Capital | 140.57M |
Cash Flow
In the last 12 months, operating cash flow was -$52.79 million and capital expenditures -$27,000, giving a free cash flow of -$52.81 million.
| Operating Cash Flow | -52.79M |
| Capital Expenditures | -27,000 |
| Free Cash Flow | -52.81M |
| FCF Per Share | -$1.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SION does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.42% |
| FCF Yield | -11.49% |
Analyst Forecast
The average price target for SION is $32.00, which is 204.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 204.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |